Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 2.31% |
| 2 | Technology | 1.26% |
| 3 | Financials | 1.12% |
| 4 | Healthcare | 1.04% |
| 5 | Consumer Discretionary | 0.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
CALL
First Solar
FSLR
$22.7B
| $73.1M | 0.04% |
1,849,900
+775,600
| +72% | +$32.1M |
|
402
PUT
Seagate
STX
$181B
| $73M | 0.04% |
1,893,200
-166,700
| -8% | -$5.41M |
|
403
PUT
American International
AIG
$40.4B
| $72.8M | 0.04% |
1,226,600
+224,700
| +22% | +$12.8M |
|
404
CALL
Direxion Daily Small Cap Bull 3x ETF
TNA
$1.29B
| $72.2M | 0.03% |
1,809,400
-52,400
| -3% | -$1.97M |
|
405
iShares MSCI Emerging Markets ETF
EEM
$30.8B
| $72.2M | 0.03% |
+1,926,568
| New | +$70.4M |
|
406
PUT
Elevance Health
ELV
$87.3B
| $72M | 0.03% |
574,200
+111,000
| +24% | +$14.3M |
|
|
ATVI
407
CALL
DELISTED
Activision Blizzard
ATVI
| $71.6M | 0.03% |
1,617,200
+505,800
| +46% | +$21.2M |
|
408
CALL
Hewlett Packard
HPE
$69.4B
| $71.6M | 0.03% |
5,413,733
+918,261
| +20% | +$11.3M |
|
|
GG
409
DELISTED
Goldcorp Inc
GG
| $71.5M | 0.03% |
4,330,189
+2,842,463
| +191% | +$50.1M |
|
410
CALL
Teva Pharmaceuticals
TEVA
$43.1B
| $70.6M | 0.03% |
1,535,300
+211,100
| +16% | +$11M |
|
411
CALL
Texas Instruments
TXN
$237B
| $70.6M | 0.03% |
1,006,300
-785,700
| -44% | -$53.6M |
|
412
CALL
Valero Energy
VLO
$99.4B
| $70.3M | 0.03% |
1,326,900
-19,500
| -1% | -$1.04M |
|
413
CALL
NetEase
NTES
$79B
| $70.3M | 0.03% |
1,459,000
+612,000
| +72% | +$26M |
|
414
Delta Air Lines
DAL
$54.5B
| $69.9M | 0.03% |
1,776,209
-587,183
| -25% | -$22.2M |
|
415
CALL
Alcoa
AA
$13.2B
| $69.8M | 0.03% |
2,863,920
-290,262
| -9% | -$7.08M |
|
416
CALL
General Mills
GIS
$21.8B
| $69.7M | 0.03% |
1,091,100
+141,000
| +15% | +$9.81M |
|
417
Salesforce
CRM
$172B
| $69.5M | 0.03% |
974,589
+949,188
| +3,737% | +$74M |
|
|
ICPT
418
CALL
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $69.1M | 0.03% |
419,900
-14,700
| -3% | -$2.32M |
|
419
CALL
Harley-Davidson
HOG
$2.94B
| $69M | 0.03% |
1,312,700
+728,900
| +125% | +$37.7M |
|
420
PUT
McKesson
MCK
$102B
| $69M | 0.03% |
413,900
-112,800
| -21% | -$21M |
|
421
PUT
GoPro
GPRO
$113M
| $68.8M | 0.03% |
4,123,000
+1,340,900
| +48% | +$18.4M |
|
422
PUT
Williams Companies
WMB
$86.6B
| $68.5M | 0.03% |
2,228,900
+547,300
| +33% | +$14.5M |
|
423
CALL
State Street Health Care Select Sector SPDR ETF
XLV
$45.3B
| $68.1M | 0.03% |
944,100
-2,019,900
| -68% | -$149M |
|
424
CALL
iShares Silver Trust
SLV
$33.5B
| $67.7M | 0.03% |
3,719,700
+126,500
| +4% | +$2.36M |
|
425
PUT
Direxion Daily Gold Miners Index Bull 2X ETF
NUGT
$1.5B
| $67.5M | 0.03% |
178,320
-260,055
| -59% | -$138M |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass deployed $7.57B of net new capital in Q3 2016, opening 1,347 new positions and adding to 3,275 existing holdings. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
By sector, the portfolio is most concentrated in Consumer Staples at 2.3% of assets, up from 0.28% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Apple, an estimated $762M trimmed.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.